Immunoreactivity and receptor binding of mixed recombinants of human growth hormone and chorionic somatomammotropin.

AUTOR(ES)

Burstein, S

RESUMO

The behavior in six radioligand assays of the recombinant obtained by the noncovalent complementation of the reduced and carbamoylmethylated 134-residue amino-terminal fragment of human growth hormore with the reduced and carbamoylmethylated 51-residue carboxyl-terminal fragment of human chorionic somatomammotropin was compared to that of the analogous recombinant of the 133-residue amino-terminal fragment of human chorionic somatomammotropin and the 51-residue carboxyl-terminal fragment of human growth hormone. The determinants for the hepatic growth hormone receptor binding and for the lactogenic receptor binding of human growth hormone are on the amino-terminal fragments. The antigenic determinants for both a monospecific antiserum to human growth hormone and a monospecific antiserum to human chorionic somatomammotropin also are on the amino-terminal fragments of their respective antigens. The mixed recombinant of the amino-terminal fragment of human growth hormone with the carboxyl-terminal fragment of human chorionic somatomammotropin retains full radioimmuno- and radioreceptor activity after lyophilization.

Documentos Relacionados

• Structure of genes for human growth hormone and chorionic somatomammotropin.
• Relative levels of methylation in human growth hormone and chorionic somatomammotropin genes in expressing and non-expressing tissues.
• Human chorionic somatomammotropin and growth hormone gene expression in rat pituitary tumour cells is dependent on proximal promoter sequences.
• Study on dioxan separation in the radioimmunoassay of human growth hormone, human chorionic gonadotrophin, adrenocorticotrophic hormone, and insulin
• Antigenic, receptor-binding and mitogenic activity of proteolytic fragments of human growth hormone.